Rep. Richard McCormick Buys UnitedHealth Group Incorporated (NYSE:UNH) Stock

Representative Richard McCormick (Republican-Georgia) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in UnitedHealth Group stock on March 19th. The trade occurred in the Representative’s “GROWTH PARTNERS ROTH IRA” account.

Representative Richard McCormick also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Automatic Data Processing (NASDAQ:ADP) on 3/19/2026.
• Sold $1,001 – $15,000 in shares of NextEra Energy (NYSE:NEE) on 3/19/2026.
• Purchased $1,001 – $15,000 in shares of Abbott Laboratories (NYSE:ABT) on 3/19/2026.
• Sold $1,001 – $15,000 in shares of Analog Devices (NASDAQ:ADI) on 3/19/2026.
• Purchased $1,001 – $15,000 in shares of Home Depot (NYSE:HD) on 3/19/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 3/19/2026.
• Sold $1,001 – $15,000 in shares of Automatic Data Processing (NASDAQ:ADP) on 3/19/2026.
• Purchased $1,001 – $15,000 in shares of BlackRock (NYSE:BLK) on 3/19/2026.
• Sold $1,001 – $15,000 in shares of L3Harris Technologies (NYSE:LHX) on 3/19/2026.
• Sold $1,001 – $15,000 in shares of Johnson & Johnson (NYSE:JNJ) on 3/19/2026.

UnitedHealth Group Stock Down 0.5%

UnitedHealth Group stock opened at $306.29 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $606.36. The company has a market cap of $278.02 billion, a PE ratio of 23.22, a price-to-earnings-growth ratio of 1.28 and a beta of 0.40. The stock’s 50 day moving average price is $282.36 and its 200 day moving average price is $318.95.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the business earned $6.81 earnings per share. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Investors of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.9%. UnitedHealth Group’s payout ratio is 67.02%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on UNH shares. Royal Bank Of Canada decreased their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Sanford C. Bernstein boosted their target price on UnitedHealth Group from $405.00 to $411.00 and gave the stock an “outperform” rating in a research report on Tuesday. Barclays decreased their target price on UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Finally, Morgan Stanley decreased their target price on UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a research report on Friday, January 23rd. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $363.42.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS raised 2027 Medicare Advantage payments by ~2.48%, a surprise above street expectations — this directly improves UnitedHealth’s revenue and margin outlook for Medicare Advantage and triggered a broad relief rally across managed-care names. UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears
• Positive Sentiment: Several sell-side analysts raised price targets and upgraded UNH after the CMS decision (example: BofA and Sanford C. Bernstein moves), contributing to the near-term re-rating and higher trading volume. UnitedHealth Price Target Raised to $337 by BofA After Medicare Advantage Rate Finalization
• Positive Sentiment: Street research and note-writers are quantifying meaningful upside from the CMS move (several pieces estimate billions in incremental revenue/operating profit and reduced downside risk), which supports expectations for margin recovery driven by UnitedHealth’s scale and Optum capabilities. UnitedHealth Could Reprice Soon: The Catalyst Is Here
• Neutral Sentiment: Wall Street remains broadly constructive on UNH: ~75% of covering analysts rate the stock bullishly with a consensus target around $355, and UNH is highlighted among hedge-fund favorites — that supports medium-term investor interest but already implies some upside is priced in. Analysts Remain Confident in UnitedHealth (UNH)’s Growth Initiatives Outside of Its Main Insurance Operations
• Neutral Sentiment: Recent fundamental context: UnitedHealth beat Q4/most-recent EPS estimates and provided FY-level guidance, which underpinned confidence before the CMS news — but consensus EPS forecasts remain materially higher than some boutique analyst raises. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
• Negative Sentiment: Caution: commentators warn the Medicare tailwind may be partially priced in after the large one-day rally and the stock faces near-term catalysts (upcoming quarterly results) that could reintroduce volatility if guidance or cost trends disappoint. UnitedHealth Stock Jumps on Better-Than-Expected Medicare Advantage Rates. Here’s Why the Rally Might Be Short-Lived
• Negative Sentiment: Macroeconomic and cost risks remain (medical-cost inflation, optical/claims mix, and broader interest-rate/market moves). Those factors plus profit-taking after the run-up explain why UNH has pulled back from its intraday highs. UnitedHealth (UNH) Soars 9.4%: Is Further Upside Left in the Stock?

Institutional Trading of UnitedHealth Group

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Sarver Vrooman Wealth Advisors acquired a new position in UnitedHealth Group in the fourth quarter valued at $25,000. Beacon Financial Strategies CORP acquired a new position in UnitedHealth Group in the fourth quarter valued at $26,000. Anfield Capital Management LLC increased its stake in UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. Joseph Group Capital Management acquired a new position in UnitedHealth Group in the fourth quarter valued at $27,000. Finally, Nalls Sherbakoff Group LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $27,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

About Representative McCormick

Rich McCormick (Republican Party) is a member of the U.S. House, representing Georgia’s 7th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

McCormick (Republican Party) is running for re-election to the U.S. House to represent Georgia’s 7th Congressional District. He declared candidacy for the 2026 election.

Rich McCormick lives in Suwanee, Georgia. McCormick served in the U.S. Marine Corps and the U.S. Navy. He earned an M.B.A. from National University and an M.D. from Morehouse School of Medicine. McCormick’s career experience includes working as an emergency medicine physician with Gwinnett Medical Center and Northside Hospital, a Marine officer instructor with Georgia Tech and Morehouse College, and a pilot.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.